Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Palisade Bio Inc (PALI)

Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC) GlobeNewswire - Thu Nov 21, 7:15AM CST

PALI : 2.46 (+0.82%)
Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit GlobeNewswire - Thu Nov 14, 8:00AM CST

PALI : 2.46 (+0.82%)
Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108 GlobeNewswire - Tue Nov 12, 7:45AM CST

PALI : 2.46 (+0.82%)
Palisade Bio Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis (UC) GlobeNewswire - Thu Nov 7, 7:30AM CST

PALI : 2.46 (+0.82%)
Palisade Bio Announces Positive Data from Two Ex Vivo Translational Studies of PALI-2108 for the Treatment of Ulcerative Colitis GlobeNewswire - Thu Oct 31, 7:30AM CDT

PALI : 2.46 (+0.82%)
Palisade Bio Announces Abstract Accepted for Presentation at the American College of Gastroenterology’s (ACG) 2024 Annual Scientific Meeting GlobeNewswire - Tue Oct 15, 7:00AM CDT

PALI : 2.46 (+0.82%)
Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC) GlobeNewswire - Thu Oct 10, 7:30AM CDT

PALI : 2.46 (+0.82%)
Palisade Bio to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC GlobeNewswire - Tue Oct 8, 7:00AM CDT

PALI : 2.46 (+0.82%)
JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023 ACCESSWIRE - Wed Oct 18, 2023

- Live video webcast interactive Q&A with participating companies -

EVFM : 0.0099 (-1.00%)
GRI : 0.6900 (+7.98%)
MBRX : 2.78 (+4.12%)
XBIO : 3.88 (-2.73%)
AREC : 1.1100 (+4.72%)
CNSP : 0.1303 (+5.42%)
NVNO : 3.28 (-2.67%)
PALI : 2.46 (+0.82%)
Palisade Bio (NASDAQ: PALI) Awarded Fast Track Designation from U.S. FDA for LB1148 Spotlight Growth - Tue Nov 22, 2022

Palisade Bio, Inc. (NASDAQ: PALI) is engaged as a biopharmaceutical company, which is focused on the research and development of

PALI : 2.46 (+0.82%)

Barchart Exclusives

Are Cattle Prices Heading for Record Highs in 2025? Barchart - 33 minutes ago
Live and cattle feeder futures prices have risen since the 2020 pandemic-inspired lows. After reaching record highs in 2024, cattle futures are consolidating, and new highs could be on the horizon in 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot